Praxsyn Corporation (PXYN)
Praxsyn Corporation operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,347. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -695.5%. Its beta of 0.80 implies it has historically moved less than the broad market.
Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.
Praxsyn Corporation is most often compared with the following Healthcare names: